Mid-weight oncology stocks: The dark horses of cancer research
18 No. of Symbols
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.83 USD
−125.04 M USD
0.00 USD
163.34 M
About Erasca, Inc.
Sector
CEO
Jonathan E. Lim
Headquarters
San Diego
Website
Founded
2018
FIGI
BBG00MTSR883
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim on July 1, 2018 and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ERAS is featured.
Frequently Asked Questions
The current price of ERAS is 2.70 USD — it has increased by 3.85% in the past 24 hours. Watch Erasca, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Erasca, Inc. stocks are traded under the ticker ERAS.
ERAS stock has fallen by −4.26% compared to the previous week, the month change is a 1.50% rise, over the last year Erasca, Inc. has showed a 19.47% increase.
We've gathered analysts' opinions on Erasca, Inc. future price: according to them, ERAS price has a max estimate of 7.00 USD and a min estimate of 3.50 USD. Watch ERAS chart and read a more detailed Erasca, Inc. stock forecast: see what analysts think of Erasca, Inc. and suggest that you do with its stocks.
ERAS reached its all-time high on Sep 7, 2021 with the price of 24.47 USD, and its all-time low was 1.51 USD and was reached on Dec 1, 2023. View more price dynamics on ERAS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ERAS stock is 8.95% volatile and has beta coefficient of 1.81. Track Erasca, Inc. stock price on the chart and check out the list of the most volatile stocks — is Erasca, Inc. there?
Today Erasca, Inc. has the market capitalization of 763.36 M, it has decreased by −2.62% over the last week.
Yes, you can track Erasca, Inc. financials in yearly and quarterly reports right on TradingView.
Erasca, Inc. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
ERAS earnings for the last quarter are −0.11 USD per share, whereas the estimation was −0.17 USD resulting in a 34.16% surprise. The estimated earnings for the next quarter are −0.13 USD per share. See more details about Erasca, Inc. earnings.
Erasca, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ERAS net income for the last quarter is −31.20 M USD, while the quarter before that showed −63.20 M USD of net income which accounts for 50.63% change. Track more Erasca, Inc. financial stats to get the full picture.
No, ERAS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 126.00 employees. See our rating of the largest employees — is Erasca, Inc. on this list?
Like other stocks, ERAS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Erasca, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Erasca, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Erasca, Inc. stock shows the buy signal. See more of Erasca, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.